Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Join
FREE
Home
Oncology
Prof Dr Yves Chalandon
Prof Dr Yves Chalandon
6 Dec 2018
Oncology
Share:
More great content like this
- straight to your inbox >
Related To This Subject
Oncology
9th
July
Dr Erika Hamilton
Oncology
9th
July
Prof Brian van Tine
More articles
Oncology
12
Mins
2 Dec 2025
Multi-omics Insights for Biomarkers in NSCLC
Oncology
7
Mins
2 Dec 2025
Immune Checkpoint Inhibitor-Associated Hydropneumothorax
Oncology
6
Mins
2 Dec 2025
Recurrent Plexiform Neurofibroma with KRAS and AKT1 Mutations
Featured journals
Oncology
December 2025
EMJ Oncology 13.1 2025
Oncology
October 2025
AMJ Oncology 2.1 [Supplement 3] 2025
We’ve noticed you’re accessing
from
North/South America.
View
View
